Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cardiac CT Algorithm Quantifies Aortic Valve Calcium

By HospiMedica International staff writers
Posted on 22 Feb 2021
A new study shows that an artificial intelligence (AI) model can automatically detect aortic valve calcium (AVC) on cardiac CT, and is superior to visual grading by radiologists. More...


Developed by researchers at the Catholic University of Korea (Seoul, South Korea), Yonsei University College of Medicine (Seoul, South Korea), and other institutions, the deep learning (DL)-based algorithm was initially trained and validated on 452 non-enhanced electrocardiogram-gated cardiac CT scans. It was then tested on a separate set of 137 cases, with each CT exam manually annotated by a radiologist with seven years of experience in cardiothoracic imaging, and AVC volume and Agatston scores were compared.

The results revealed that when manually measured AVC Agatston score was used as a benchmark, the accuracy of DL-measured AVC Agatston score for AVC volume grading was 97%, which was better than that of the four radiologist readers (77.8–89.9 %). The accuracy of DL algorithm for Agatston score was 92.9%. Overall, the DL model was deemed to be superior to all four radiologists for predicting severe aortic valve calcium cases. The study was published on February 6, 2021, in European Journal of Radiology.

“For observer performance testing, four radiologists determined AVC grade in two reading rounds. The diagnostic performance of DL-measured AVC volume and Agaston score for classifying severe AVC was compared with that of each reader's assessment,” explained lead author Suyon Chang, MD, of the Catholic University of Korea, and colleagues. “To validate AVC segmentation performance, the Dice coefficient [a statistic used to gauge the similarity of two samples] was calculated; after applying the DL algorithm, the Dice coefficient score was 0.807.”

The Agatston score is a semi-automated tool to calculate the extent of coronary artery calcification detected by an unenhanced low-dose CT scan, which is routinely performed in patients undergoing cardiac CT. It allows for early risk stratification as patients with a high Agatston score (over 160) have an increased risk for a major adverse cardiac event (MACE). Although it does not allow for the assessment of soft non-calcified plaques, it has shown a good correlation with contrast-enhanced CT coronary angiography.

Related Links:
Catholic University of Korea
Yonsei University College of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.